Search

Adrian J Hepner

from Woodcliff Lake, NJ
Age ~62
Get Report
Also known as:
Adrian Javier Hepner, Claudia M Hepner, Adrian Heoye, Adrian Hefner, Claudia M Cogan, Claudia M Hedner, Adrian R, Stacy Carns
Related to:
Stephanie HepnerAlan HepnerStephanie Hepner, 33
Connected to:
Devin J Hepner, 42Diane P Hepner, 72Krista Hepner, 58Leslie D Hepner, 42Miriam J Hepner, 79Valerie B Hepner, 56Al HeppNicolas A Hepp, 35Pamela E Hepp, 58Sharon I Hepp, 73

Adrian Hepner Phones & Addresses

  • Woodcliff Lake, NJ
  • Ramsey, NJ
  • Raleigh, NC
  • Aliso Viejo, CA
  • 42 Hillrise, Trabuco Canyon, CA 92679 (949) 713-2390
  • Dove Canyon, CA
  • Aventura, FL
  • Orange, CA
  • 5009 Clyden Cv, Raleigh, NC 27612

Work

Position: Clerical/White Collar

Education

Degree: High school graduate or higher

Publications

Us Patents

Methods Of Using Dantrolene To Treat Nerve Agent Exposure

View page
US Patent:
20200383954, Dec 10, 2020
Filed:
Sep 5, 2018
Appl. No.:
16/644281
Inventors:
- Woodcliff Lake NJ, US
Adrian HEPNER - Woodcliff Lake NJ, US
International Classification:
A61K 31/4178
A61K 31/5517
A61P 25/28
A61K 31/444
A61K 31/46
A61P 25/08
Abstract:
The disclosure is directed to methods of treating subjects exposed to nerve agents with dantrolene, or a pharmaceutically acceptable salt thereof.

Fulvestrant Formulations And Methods Of Their Use

View page
US Patent:
20200360284, Nov 19, 2020
Filed:
Nov 8, 2018
Appl. No.:
16/762229
Inventors:
- Woodcliff Lake NJ, US
Steven L. KRILL - Midland Park NJ, US
Rama Abu SHMEIS - Branchburg NJ, US
Adrian HEPNER - Ramsey NJ, US
Charles WESCOTT - Woodcliff Lake NJ, US
Tara JASKOWSKI - Woodcliff Lake NJ, US
Michael JOYCE - Woodcliff Lake NJ, US
International Classification:
A61K 9/10
A61K 31/566
A61K 47/32
A61K 47/26
A61K 9/00
A61K 31/519
A61K 47/24
Abstract:
The present disclosure provides methods of treating breast cancer including administering aqueous suspensions comprising solubilized fulvestrant, non-solubilized fulvestrant particles having one or more of an LD Dv(10) between about 1.5 and about 2.1 microns, an LD Dv(50) between about 5.5 and about 9.0 microns, and an LD Dv(90) between about 15 and about 35 microns, with the aqueous suspensions further including a surfactant, a polyvinylpyrrolidone, and a sugar alcohol, and a water-soluble excipient. The water-soluble excipient can be an aryl-Ci-6alk-OH, a Ci-6alkyl-OH, a buffering salt, a polysorbate, a polyalkylene glycol, a Ci-i2alkylene glycol, a phosphatidylcholine, or a combination thereof.

Dantrolene Prodrugs And Methods Of Their Use

View page
US Patent:
20200239455, Jul 30, 2020
Filed:
Oct 19, 2018
Appl. No.:
16/755255
Inventors:
- Qormi, MT
Adrian HEPNER - Ramsey NJ, US
Alyssa LARSON - Needham MA, US
International Classification:
C07D 405/12
A61K 9/00
Abstract:
The disclosure is directed to dantrolene prodrugs, compositions thereof, and methods of their use in the treatment of disease.
Control profile
Adrian J Hepner from Woodcliff Lake, NJ, age ~62 Get Report